Eye Movement Behaviour and Pupil Size in Natural Outdoor and Indoor Scenes
NCT ID: NCT05971238
Last Updated: 2023-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2023-07-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Attention and Eye Movements
NCT03298737
Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies
NCT03811964
Visual Perception Exploration Using Eye-tracking Technology in High-fidelity Medical Simulation
NCT03049098
Moderators and Mediators of Perceptual Learning
NCT05894967
Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures
NCT05476523
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eye-tracking, pupillometry and scene rating indoors & outdoors
Indoor vs. outdoor scenes
Light conditions in indoor (artificial light) and outdoor (daylight) settings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indoor vs. outdoor scenes
Light conditions in indoor (artificial light) and outdoor (daylight) settings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal or corrected-to-normal visual acuity (+3dpt. to -5dpt.)
* Normal colour vision
* Normal binocular vision
Exclusion Criteria
* Excessive alcohol and/or drug use
* Presence of psychiatric disorders
* Poor sleep quality
* Diagnosed with epilepsy
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Max-Planck Institute for Biological Cybernetics
OTHER
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manuel Spitschan
Assistant Professor of Chronobiology & Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuel Spitschan, PhD
Role: PRINCIPAL_INVESTIGATOR
Technical University of Munich & Max Planck Institute for Biological Cybernetics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Max Planck Institute for Biological Cybernetics
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alexander Hahn
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-231-S-KH
Identifier Type: OTHER
Identifier Source: secondary_id
MPI-TSCN-2023-NATURALEYE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.